Biomea Fusion, Inc. (BMEA)
2.03
+0.12 (6.28%)
Upcoming Events
Latest Headlines
Biomea Fusion to Participate in Upcoming Investor Conferences
September 3, 2026 8:00 AM - StreetInsider
H.C. Wainwright on Biomea Fusion Inc. (BMEA) amid 17% Gain: 'Another step toward confirmatory Phase 2 data and T2D development strategy'
August 24, 2026 9:43 AM - StreetInsider
Biomea Fusion completes enrollment in Phase II diabetes trial
August 24, 2026 7:03 AM - StreetInsider
Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes
August 24, 2026 7:00 AM - StreetInsider
Biomea Fusion doses first patient in obesity combo drug study
August 13, 2026 7:02 AM - StreetInsider
Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
August 13, 2026 7:00 AM - StreetInsider
Citi opens 90-day Positive catalyst watch on Biomea Fusion
August 11, 2026 4:48 AM - StreetInsider
Biomea Fusion, Inc. (BMEA) Tops Q2 EPS by 9c
August 5, 2026 6:18 PM - StreetInsider
Form 10-Q Biomea Fusion, Inc. For: Jun 30
August 5, 2026 4:13 PM - SEC Filing
Form 8-K Biomea Fusion, Inc. For: Aug 05
August 5, 2026 4:11 PM - SEC Filing
Biomea Fusion Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 5, 2026 4:06 PM - Globe NewsWire
JPMorgan analysts name top short ideas for third quarter 2026
July 10, 2026 11:12 AM - StreetInsider
Oppenheimer Assumes Biomea Fusion Inc. (BMEA) at Outperform
June 23, 2026 4:34 PM - StreetInsider
Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Ray Sumita
June 12, 2026 4:16 PM - SEC Filing
Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: AGUIAR ERIC
June 12, 2026 4:16 PM - SEC Filing
Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Faust Elizabeth
June 12, 2026 4:16 PM - SEC Filing
Form 4 Biomea Fusion, Inc. For: Jun 10 Filed by: Averill Julianne
June 12, 2026 4:15 PM - SEC Filing
Form 8-K Biomea Fusion, Inc. For: Jun 10
June 11, 2026 7:12 AM - SEC Filing
Full Article List
